Advanced Biomed Inc.
For the period ended Jun 30, 2025. Filed Oct 8, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Oct 8, 2025
ADVB$2.11+2.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
ITEM 15. Exhibits and Financial Statements Schedules
| (a) | The following documents are filed as part of this Report: |
|---|
| (1) | Consolidated Financial Statements |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| PAGE | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets as of June 30, 2025 and 2024 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss for the Financial Years Ended June 30, 2025 and 2024 | F-4 |
| Consolidated Statements of Changes in Stockholders’ Equity for the Financial Years Ended June 30, 2025 and 2024 | F-5 |
| Consolidated Statements of Cash Flows for the Financial Years Ended June 30, 2025 and 2024 | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.